CHU de Nice
Nice, 06000, France
Location status: Recruiting
NCT Number: NCT05343286
Physical activity is one of the most effective therapeutic interventions for frailty, sarcopenia or dynapenia. The benefits of physical activity processes are already widely documented. Typically, researchers want to understand the average response to an intervention to determine its overall effectiveness. However, sports trainers have understood it for a long time, the response of an athlete or a patient to training is very variable and the standard deviations present in all the scientific studies on the subject confirm it. There is therefore inter-individual variation in the response to exercise, with some subjects showing much greater improvements than others. Thus, one can wonder if this "non-response" following training is specific to the training modality. The effects of physical exercise on the body depend mainly on its type, intensity and duration. Thus, from a practical point of view, the most important perspective is the prediction and, ultimately, the individual optimization of management through physical activity.
Interested in participating?
Request Info60 year and older
All sexes
Interventional
Not applicable
Nice, 06000, France
Location status: Recruiting
Main objective: To determine the effects of personalized physical activity management on the biological signatures of muscle failure.
Secondary objectives:
Phenotype responders and non-responders in training
900 seniors (300 per group) APAP group: adapted and personalized physical activity APA group: adapted physical activity Control group: no physical activity
Total duration of the study 5 years, duration of participation for a patient 3 months; inclusion period: 57 months
Improvement of muscle failure in its broad definition (Strength, power, speed and lean mass)
) General data: description of characteristics with frequencies and percentage for categorical variables and with mean and standard deviation for quantitative variables.
ii) Analysis of the primary endpoint: Machine Learning (or supervised classification) and signaling pathway prediction approaches for statistical analysis and data interpretation.
iii) Analysis of secondary judgment criteria: approaches in Machine Learning (or supervised classification) and signaling pathway prediction for statistical analysis and interpretation of data with comparison of quantitative variables by Pearson correlation and categorical variables by t or chi 2 test depending on the case.
Adapt and individualize physical activity support for healthy or frail elderly people
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
blood sample before and after 12 weeks of physical activity
physical assessement before and after 12 weeks of physical activity
Psychometric questionnaires
Time frame: before and after 12 week of physical activity program
muscle power (Watt/Kg) assessed with the isokinetic ergometer.
Time frame: at day 0
Change in the amino acid composition (metabolomic signature) at Day 0 between the groups
Time frame: between Day 0 and Month 3
Change in the amino acid composition (metabolomic signature) after 3 month of physical activity for the APA and APAP groups compared to the no physical activity group
Time frame: before and after 12 week of physical activity program
Score of frailty. (Implementation of the Integrated Care of Older People, ICOPmonitor, 8 item, higher score means worse outcome)
Time frame: before and after 12 week of physical activity program
number of movement
Time frame: before and after 12 week of physical activity program
Gait velocity in m.s-1
Time frame: before and after 12 week of physical activity program
% of lean mass
Time frame: before and after 12 week of physical activity program
Score Mini-Mental State Examination (MMSE, 0-30, higher score mean worse outcome)
Time frame: before and after 12 week of physical activity program
Score of Big Five Inventory, 0-44, higher score means worse outcome
Time frame: before and after 12 week of physical activity program
Score of the scale, 0-6, higher score means better outcome
Time frame: before and after 12 week of physical activity program
Subjective age in years
Time frame: before and after 12 week of physical activity program
Age group identification in years
Time frame: before and after 12 week of physical activity program
Score on the French version of the Attitudes Toward Own Aging scales, 0-7, higher score means better outcome
Time frame: before and after 12 week of physical activity program
Score on the French version of the Physical Self-Perception Profile, 0-6, higher score means better outcome
Time frame: before and after 12 week of physical activity program
Score on the Motivation Scale for Physical Activity in a Health Context,0-30, higher score means better outcome
Time frame: before and after 12 week of physical activity program
Score on the French Aging Stereotypes and Exercise Scale (ASES), 0-12, higher score means better outcome
Time frame: before and after 12 week of physical activity program
Improvement of muscle force (N/Kg) assessed with the isokinetic ergometer.
Contact information is provided by the study sponsor or research team.
Fréderic CHORIN, PhD
CONTACT
Olivier GUERIN, PU-PH
CONTACT
Centre Hospitalier Universitaire de Nice
Other
Biological & Fonctional Signatures for Muscle Failures, Aged People & Personalized Physical Activity : BioFaSt MAPPA
Acronym: BioFaSt
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07355192
Arterial Occlusive Diseases, Arteriosclerosis
Milwaukee, Wisconsin, United States
View Trial DetailsNCT05765656
Anxiety, Anxiety Disorders
Nantes, France
View Trial DetailsNCT04179981
Apnea, COPD
Detroit, Michigan, United States
View Trial DetailsNCT06961578
Atlanto-Axial Fusion, Elderly
Munich, Bavaria, Germany
View Trial Details